Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23688323 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Efficacy, Safety, and Tolerability of SAR231893 (REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Condition: Asthma
Interventions: Biological: SAR231893 (REGN668);   Drug: placebo;   Drug: Fluticasone/Salmeterol combination;   Drug: Fluticasone;   Drug: Albuterol

Indicates status has not been verified in more than two years